This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Chimera Investment (CIM) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of 16.13% and 12.83%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chimera Investment (CIM) Enters Overbought Territory: Is A Drop Coming?
by Zacks Equity Research
Chimera Investment (CIM) has moved higher as of late, but there could definitely be trouble on the horizon for this company
Chimera Investment (CIM) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of -9.38% and -5.80%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chimera Investment (CIM) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of 6.45% and 11.93%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Here's How Chimera (CIM) Looks Just Ahead of Q3 Earnings
by Zacks Equity Research
Low LIBOR rates during the third quarter are likely to lead to have reduced interest income for Chimera's (CIM) floating-rate investments.
Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top Ranked Income Stocks to Buy for October 5th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, October 5th
Here's Why AGNC Investment Deserves a Place in Your Portfolio
by Zacks Equity Research
Timely changes in investment portfolio amid the ongoing Agency market-recovery phase and a strong financial position make AGNC Investment (AGNC) a compelling investment option.
Chimera (CIM) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Chimera (CIM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Factors Influencing Chimera's (CIM) Fate this Earnings Season
by Zacks Equity Research
Chimera's (CIM) Q2 NII results are expected to reflect the impacts of the loss of interest income earned on its Agency residential mortgage-backed investment due to the sale of the portfolio in Q1.
Chimera Investment (CIM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Chimera Investment (CIM) closed the most recent trading day at $9.16, moving +0.88% from the previous trading session.
Earnings Preview: Chimera Investment (CIM) Q2 Earnings Expected to Decline
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for July 14th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Top Ranked Income Stocks to Buy for June 29th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, June 29th
Top Ranked Income Stocks to Buy for June 26th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, June 26th
Top Ranked Income Stocks to Buy for June 22nd
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, June 22nd
Top Ranked Income Stocks to Buy for June 17th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, June 17th
Top Ranked Income Stocks to Buy for June 11th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, June 11th
Two Harbors Investment (TWO) in Focus: Stock Moves 6.4% Higher
by Zacks Equity Research
Two Harbors Investment (TWO) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Implied Volatility Surging for Chimera Investment (CIM) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Chimera Investment (CIM) stock based on the movements in the options market lately.
Chimera Investment (CIM) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of 78.13% and 35.30%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Chimera Investment (CIM) Stock Moves -0.9%: What You Should Know
by Zacks Equity Research
In the latest trading session, Chimera Investment (CIM) closed at $7.70, marking a -0.9% move from the previous day.
What's in the Offing for Chimera (CIM) this Earnings Season?
by Zacks Equity Research
Volatility in the mortgage market and wider Agency MBS spreads are anticipated to have affected Chimera's (CIM) book value in Q1.